Thromb Haemost 1973; 29(01): 011-026
DOI: 10.1055/s-0038-1647742
Original Article
Schattauer GmbH

Vessel Wall and Thrombogenesis - Endotoxin[*]

Donald G McKay M. D.
1   Department of Pathology, University of California School of Medicine, San Francisco General Hospital, San Francisco, California 94110
› Author Affiliations
Further Information

Publication History

Received 21 September 1972

Publication Date:
24 July 2018 (online)

Summary

The generalized Shwartzman reaction is a definitive disease process which is the result of two minor episodes of acute inflammation of the circulating blood. The identifying feature of the reaction is thrombosis of the micro circulation, specifically of glomerular capillary thrombosis which persists long enough to cause bilateral renal cortical necrosis. The reaction is the result of an interplay between leukocytes, platelets, complement, the contact system, the extrinsic prothrombin activator system, adrenal glucocorticoids, adrenal catecholamines, alpha - adrenergic receptor sites and the fibrinolytic enzyme system. The reaction occurs only when these systems are affected within narrow quantitative limits. It is a model of the effects of bacterial endotoxin on the blood-vascular system and has important implications for acute inflammatory episodes of the circulating blood induced by other inflammatory agents such as antigen-antibody complex and particulate matter.

* Presented at the Third CongresR of the International flociety on Thrombosis and Haemostasis.


 
  • References

  • 1 Barth P, Kommeeell B, Marti M. 1970. The influence of purified contact activation product on the development of thrombi. XIII. International Congress of Hematology; Munich: 1970: 368 Abstract
  • 2 Beeson P. B. 1947; Effect of reticuloendothelial blockade on immunity to the Shwartzman phenomenon. Proceedings of the Society of Experimental Biology and Medicine 64: 146.
  • 3 Bergstein J. M, Michael Jr A. F. 1972; Renal cortical fibrinolytic activity in the rabbit following one and two doses of endotoxin. Federation Proceedings 31: 2426.
  • 4 Borgstrom S, Gelin L. E, Zederfeldt B. 1959; The formation of vein thrombi following tissue injury : An experimental study in rabbits. Acta chirurgica Scandinavica (Suppl.) 247: 1.
  • 5 Cochrane C. G, Müller-Eberhard H. J. 1968; The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. Journal of Experimental Medicine 127: 371.
  • 6 Des Prez R. M, Horowitz H. I, Hook E. W. 1961; Effects of bacterial endotoxin on rabbit platelets. I. Platelet aggregation and release of platelet factors in vitro. Journal of Experimental Medicine 114: 857.
  • 7 Deykin D, Chun R, Lopez A, Silversmith P. 1966; The role of the liver in serum- induced hypercoagulability. Journal of Clinical Investigation 45: 256.
  • 8 Egdahl R. H. 1959; The differential response of the adrenal cortex and medulla to bacterial endotoxin. Journal of Clinical Investigation 38: 1120.
  • 9 Evans G, Mustard J. F. 1968; Inhibition of the platelet surface reaction in endotoxin shock and the generalized Shwartzman reaction. Journal of Clinical Investigation 47: 31a Abstract
  • 10 Fong J SC, Good R. A. 1971; Prevention of the localized and generalized Shwartzman reactions by an anti-complementary agent, cobra venom factor. Journal of Experimental Medicine 134: 642.
  • 11 Good R. A, Thomas L. 1953; Studies on the generalized Shwartzman reaction. IV. Prevention of the local and generalized Shwartzman reaction with heparin. Journal of Experimental Medicine 97: 871.
  • 12 Horn R. G, Collins R. D. 1968; Studies on the pathogenesis of the generalized Shwartzman reaction. The role of granulocytes. Laboratory Investigation 18: 101.
  • 13 Kliman A, McKay D. G. 1958; Prevention of the generalized Shwartzman phenomenon by fibrinolysis. Federation Proceedings 17: 443.
  • 14 Latour J-G, McKay D. G. 1970; Requirement of the adrenal glands for provocation of the generalized Shwartzman reaction. Laboratory Investigation 22: 281.
  • 15 Latour J-G, Prejean J. B, Margaretten W. 1971; Corticosteroids and the generalized Shwartzman reaction: Mechanisms of sensitization in the rabbit. American Journal of Pathology 65: 189.
  • 16 Lepri G, Cristiani R. 1964; Ability of certain adrenocortical hormones to potentiate the vasoconstrictor action of noradrenaline on the conjunctival vessels in the rabbit and in man. British Journal of Ophthalmology 48: 205.
  • 17 Lerner R. G, Rapaport S. I, Spitzer J. M. 1968; Endotoxin induced intravascular clotting : The need for granulocytes. Thrombosis et Diathesis Haemorrhagica 20: 430.
  • 18 Margaretten W, McKay D. G. 1969; The role of the platelet in the generalized Shwartzman reaction. Journal of Experimental Medicine 129: 585.
  • 19 Margaretten W, Zunker H. O, McKay D. G. 1964; Production of the generalized Shwartzman reaction in pregnant rats by intravenous infusion of thrombin. Laboratory Investigation 12: 552.
  • 20 Melmon K. L, Cline M. J. 1968; The interaction of leukocytes and the kinin system. Biochemical Pharmacology Suppl 271.
  • 21 Muller-Berghaus G, Davidson E, McKay D. G. 1967; Prevention of the generalized Shwartzman reaction in pregnant rats by alpha-adrenergic blockade. Effects on the coagulation mechanism. Obstetrics and Gynecology 30: 774.
  • 22 Muller-Berghaus G, McKay D. G. 1967; Prevention of the generalized Shwartzman reaction in pregnant rats by alpha-adrenergic blocking agents. Laboratory Investigation 17: 276.
  • 23 Muller-Berghaus G, Schneberger R. 1971; Hageman Factor activation in the generalized Shwartzman reaction induced by endotoxin. British Journal of Haematology 21: 513.
  • 24 Mustard J. F, Evans G, Packham M. A, Nishizawa E. E. 1969. The platelet in intravascular immunological reactions. In: Movat H. Z. (ed.). Cellular and Humoral Mechanisms in Anaphylaxis and Allergy. S. Karger AG, Basel; Switzerland: 151.
  • 25 McKay D. G. 1963; A partial synthesis of the generalized Shwartzman reaction. Federation Proceedings 22: 1373.
  • 26 McKay D. G, Gitlin D, Craig J. M. 1959; Immunochemical demonstration of fibrin in the generalized Shwartzman reaction. Archives of Pathology 67: 270.
  • 27 McKay D. G, Kliman A, Alexander B. 1959; Experimental production of afibrinogenemia and hemorrhagic phenomena by combined fibrinolysis and disseminated intravascular coagulation. New England Journal of Medicine 261: 1150.
  • 28 McKay D. G, Latour J-G, Lopez A. M. 1971; Production of the generalized Shwartzman reaction by activated Hageman Factor and alpha-adrenergic stimulation. Thrombosis et Diathesis Haemorrhagica 26: 71.
  • 29 McKay D. G, Latour J-G, Parrish M. H. 1970; Activation of Hageman Factor by alpha-adrenergic stimulation. Thrombosis et Diathesis Haemorrhagica 23: 417.
  • 30 McKay D. G, Margaretten W, Csavossy I. 1966; An electron microscope study of the effect of bacterial endotoxin on the blood vascular system. Laboratory Investigation 15: 1815.
  • 31 McKay D. G, Margaretten W, Phillips L. L. 1967; The role of the leukocyte in the generalized Shwartzman reaction. Laboratory Investigation 16: 511.
  • 32 McKay D. G, Muller-Berghaus G, Cruse V. 1969; Activation of Hageman Factor by ellagic acid and the generalized Shwartzman reaction. American Journal of Pathology 54: 393.
  • 33 McKay D. G, Rose F. J. 1960; The effect on the arterial vascular system of bacterial endotoxin. Laboratory Investigation 09: 117.
  • 34 Mckay D. G, Shapiro S. S. 1958; Alterations in the blood coagulation system induced by bacterial endotoxin. I. In vivo (Generalized Shwartzman Reaction). Journal of Experimental Medicine 107: 353.
  • 35 Palmerio C, Ming S. C, Frank E, Fine J. 1962; The role of the sympathetic nervous system in the generalized Shwartzman reaction. Journal of Experimental Medicine 115: 609.
  • 36 Phillips L. L. 1963. Modifications to the coagulation mechanism during pregnancy. In: Corey H. M. (ed.). Modern Trends in Human Reproduction Physiology. Butterworth and Company; Washington: 01 190.
  • 37 Phillips L. L, Margaretten W, McKay D. G. 1968; Changes in the fibrinolytic enzyme system following intravascular coagulation induced by thrombin and endotoxin. American Journal of Obstetrics and Gynecology 100: 319.
  • 38 Polak L, Turk J. L. 1969; Suppression of the hemorrhagic component of the Shwartzman reaction by anti-complement serum. Nature (London) 223: 738.
  • 39 Robbins B, Collins R. D. 1961; Studies on the Shwartzman reaction. Production of the renal lesion by intra-aortic infusion of thrombin. Federation Proceedings 20: 261.
  • 40 Shapiro S. S, McKay D. G. 1958; The prevention of the generalized Shwartzman reaction with sodium warfarin. Journal of Experimental Medicine 107: 377.
  • 41 Silver D. 1969; Vascular injury : Its effect on thrombolysis. J ournal of Trauma 09: 668.
  • 42 Sinakos Z, Caen J. P. 1967; Platelet aggregation in mammalians (human, rat, rabbit, guinea pig, horse, dog). A comparative study. Thrombosis et Diathesis Haemorrhagica 17: 99.
  • 43 Spaet T. H, Horowitz H. I, Zucker-Franklin D, Cintron J, Bierzenski J. J. 1961; Reticuloendothelial clearance of blood thromboplastin in rats. Blood 17: 196.
  • 44 Stetson C. A, Good R. x.A. 1951; Studies on the mechanism of the Shwartzman phenomenon. Evidence for the participation of polymorphonuclear leukocytes in the phenomenon. Journal of Experimental Medicine 93: 49.
  • 45 Stewart G. J, Anderson M. J. 1971; An ultrastructural study of endotoxin induced damage in rabbit mesenteric arteries. British Journal of Experimental Pathology 52: 75.
  • 46 Thomas L. 1952. In: Rheumatic Fever. A Symposium: University of Minnesota Press; 232.
  • 47 Thomas L, good R. A. 1952; The effect of cortisone on the Shwartzman reaction; the production of lesions resembling the dermal and generalised Shwartzman reactions by a single injection of bacterial toxin in cortisone-treated rabbits. Journal of Experimental Medicine 95: 409.
  • 48 Todd A. S. 1959; The histological localization of fibrinolysin activator. Journal of Pathology and Bacteriology 78: 281.
  • 49 Vassalli P, Simon G, Rouiller C. 1963; Electron microscopic study of glomerular lesion resulting from intravascular fibrin formation. American Journal of Pathology 43: 579.
  • 50 Wessler S. 1952; Studies in intravascular coagulation. I. Coagulation changes in isolated venous segments. Journal of Clinical Investigation 31: 1011.
  • 51 Wessler S. 1955; Studies in intravascular coagulation. III. The pathogenesis of serum-induced venous thrombosis. Journal of Clinical Investigation 34: 647.
  • 52 Whitaker A. N, McKay D. G, Csavossy I. 1969; Studies of catecholamine shock. I. Disseminated intravascular coagulation. American Journal of Pathology 56: 153.
  • 53 Zimmerman T. S, Aroyave C. M, Muller-Eberhard H. J. 1971; A blood coagulation abnormality in rabbits deficient in the sixth component of complement (C6) and its correction by purified C6 . Journal of Experimental Medicine 134: 1591.
  • 54 Zimmerman T. S, Muller-Eberhard H. J. 1971; Blood coagulation initiation by a complement-mediated pathway. Journal of Experimental Medicine 134: 1601.
  • 55 Zucker M. B, Grant R. 1972; Release reaction of human platelets induced by zymosan. Federation Proceedings 31: 303.
  • 56 Zweifach B. W, Shorr E, Block M. M. 1953; Influence of the adrenal cortex on behaviour of the terminal vascular bed. Annals of the New York Academy of Sciences 56: 626.